How Genomics Is Personalizing Drug Discovery
Regeneron Genetics Center’s Luca Lotta explains how population-scale genetic evidence can reveal more promising drug targets and open new possibilities for disease prevention
False
Advertisement
Related Content
Drug Discovery
Development & Clinical
Interviews
How Genomics Is Personalizing Drug Discovery
October 20, 2026
4 min read
Regeneron Genetics Center’s Luca Lotta explains how population-scale genetic evidence can reveal more promising drug targets and open new possibilities for disease prevention
Facilities & Equipment
Inside Kindeva’s New Sterile Fill-Finish Facility
October 20, 2026
5 min read
John Wichelt discusses Kindeva’s Bridgeton facility, supporting injectable programs from clinical development through commercial manufacturing, and choosing a long-term fill-finish partner
Drug Discovery
Biopharma
Interviews
Musings from The Power List: Piers Ingram
October 20, 2026
4 min read
Piers Ingram discusses the resurgence of immunology, engineering-led drug discovery, and why faster clinical execution will shape the next generation of medicines
Packaging
Standards & Regulation
Technology & Manufacturing
Making Clinical Trial Labels More Accessible
October 19, 2026
5 min read
Thoughtful label design and digital tools can help participants with dyslexia find and access essential clinical trial information